Lixte Biotech Hlds (LIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,055 | -3,036 | -1,368 | -6,313 | -4,681 |
| Accounts payable and accrued liabilities | -9 | 137 | -6 | 2 | 81 |
| Other Working Capital | -6 | 32 | -181 | 155 | 114 |
| Other Operating Activity | 678 | 420 | 283 | 1,544 | 1,082 |
| Operating Cash Flow | $-3,391 | $-2,447 | $-1,271 | $-4,612 | $-3,403 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,143 | 6 | 6 | 5,141 | 5,141 |
| Financing Cash Flow | $3,143 | $6 | $6 | $5,141 | $5,141 |
| Beginning Cash Position | 5,353 | 5,353 | 5,353 | 4,824 | 4,824 |
| End Cash Position | 5,106 | 2,913 | 4,088 | 5,353 | 6,562 |
| Net Cash Flow | $-248 | $-2,441 | $-1,265 | $530 | $1,738 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,391 | -2,447 | -1,271 | -4,612 | -3,403 |
| Free Cash Flow | -3,391 | -2,447 | -1,271 | -4,612 | -3,403 |